Tharimmune Stock Alpha and Beta Analysis
| THAR Stock | 2.08 0.18 7.96% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tharimmune. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tharimmune over a specified time horizon. Remember, high Tharimmune's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tharimmune's market risk premium analysis include:
Beta 0.37 | Alpha (0.13) | Risk 10.68 | Sharpe Ratio (0) | Expected Return (0.05) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Tharimmune |
Tharimmune Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tharimmune market risk premium is the additional return an investor will receive from holding Tharimmune long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tharimmune. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tharimmune's performance over market.| α | -0.13 | β | 0.37 |
Tharimmune expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Tharimmune's Buy-and-hold return. Our buy-and-hold chart shows how Tharimmune performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Tharimmune Market Price Analysis
Market price analysis indicators help investors to evaluate how Tharimmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tharimmune shares will generate the highest return on investment. By understating and applying Tharimmune stock market price indicators, traders can identify Tharimmune position entry and exit signals to maximize returns.
Tharimmune Return and Market Media
The median price of Tharimmune for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 2.45 with a coefficient of variation of 15.06. The daily time series for the period is distributed with a sample standard deviation of 0.37, arithmetic mean of 2.49, and mean deviation of 0.32. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab | 09/16/2024 |
2 | Acquisition by Appajosyula Sireesh of 5000 shares of Tharimmune at 1.93 subject to Rule 16b-3 | 10/08/2024 |
3 | Tharimmune Announces Upcoming Conference Presentations | 10/25/2024 |
4 | Whats Going On With Tharimmune Shares Wednesday | 10/30/2024 |
5 | Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics | 11/13/2024 |
6 | Short Interest in Tharimmune, Inc. Increases By 2,707.3 | 11/14/2024 |
7 | Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting to Support TH104 for Chronic Pruritus in Chronic Liver Disease | 11/18/2024 |
8 | Tharimmune Abandons Acquisition of Intract Pharma - MarketWatch | 11/21/2024 |
About Tharimmune Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tharimmune or other stocks. Alpha measures the amount that position in Tharimmune has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Tharimmune Upcoming Company Events
As portrayed in its financial statements, the presentation of Tharimmune's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tharimmune's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Tharimmune's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Tharimmune. Please utilize our Beneish M Score to check the likelihood of Tharimmune's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Tharimmune
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.